Viatris is a global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including our global workforce of approximately 45,000, we aim to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance.
Our contribution to the project
Our experience in pharmaceuticals; regulatory and medical affairs; IT technology, and market access and policy across the EU region. More specifically, we will contribute our current experience from the IATF ePI working group, which is working with EMA regulators and key stakeholders, to introduce electronic Product Information (PI) to the EU region.
VIATRIS™, is a new global healthcare company formed through the combination of Mylan and Upjohn, a legacy division of Pfizer. At Viatris, we see healthcare not as it is, but as it should be. We act courageously and are uniquely positioned to be a source of stability in a world of evolving healthcare needs. Our mission is to empower people worldwide to live healthier at every stage of life. Our policy goals are guided by the same factors that drive our mission: access, leadership and partnership.
Viatris, a New Kind of Healthcare Company